| COMPOSITION: | Each film coated tablet contains Cilnidipine 10 mg, Telmisartan 40 mg & Chlorthalidone 12.5 mg |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | CILNIFORD TRIO tablets contain Cilnidipine, a calcium channel blocker; Telmisartan, an angiotensin II receptor blocker (ARB); and Chlorthalidone, a thiazide-like diuretic. This combination works by relaxing blood vessels and removing excess fluid from the body to effectively lower blood pressure. It is prescribed for the treatment of hypertension, especially in patients requiring combination therapy for better blood pressure control. |
| SIDE EFFECTS: | It is generally well tolerated. The main side effects may include dizziness, headache, fatigue, increased urination, electrolyte imbalance, muscle cramps, and gastrointestinal discomfort. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
